Gorenstein Lyall A, Sonett Joshua R
Division of Thoracic Surgery, Columbia Presbyterian Medical Center, New York Presbyterian Hospital, 161 Fort Washington Avenue #301, New York, NY 10032, USA.
Surg Oncol Clin N Am. 2011 Oct;20(4):701-20. doi: 10.1016/j.soc.2011.07.009.
There have been recent advances in the treatment of non-small cell lung cancer (NSCLC). Surgical resection remains the cornerstone in the treatment of patients with stages I and II NSCLC. Anatomic lobectomy combined with hilar and mediastinal lymphadenectomy constitutes the oncologic basis of surgical resection. The surgical data favor video-assisted thoracic surgery (VATS) lobectomy over open lobectomy and have established VATS lobectomy as a gold standard in the surgical resection of early-stage NSCLC. However, the role of sublobar pulmonary resection, either anatomic segmentectomy or nonanatomic wedge resection, in patients with subcentimeter nodules may become important.
非小细胞肺癌(NSCLC)的治疗近来取得了进展。手术切除仍然是I期和II期NSCLC患者治疗的基石。解剖性肺叶切除术联合肺门和纵隔淋巴结清扫术构成了手术切除的肿瘤学基础。手术数据表明,与开放性肺叶切除术相比,电视辅助胸腔镜手术(VATS)肺叶切除术更具优势,并已将VATS肺叶切除术确立为早期NSCLC手术切除的金标准。然而,亚肺叶切除(无论是解剖性肺段切除术还是非解剖性楔形切除术)在结节小于1厘米的患者中的作用可能变得重要。